Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Centene Corporation    CNC

CENTENE CORPORATION (CNC)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
The feature you requested does not exist. However, we suggest the following feature:

Centene : Kansas Subsidiary Wins Medicaid Contract

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/22/2018 | 06:36pm CEST

ST. LOUIS, June 22, 2018 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced its Kansas subsidiary, Sunflower Health Plan, has been selected by the Kansas Department of Health and Environment to provide managed care services to KanCare beneficiaries statewide. The new contract will commence January 1, 2019.

The state's KanCare program covers low-income families, eligible pregnant women, Aged, Blind or Disabled (ABD), long-term care beneficiaries and the Children's Health Insurance Program (CHIP). Approximately 400,000 Kansans are enrolled in KanCare, which provides medical and behavioral health benefits as well as long-term services and supports (LTSS). KanCare managed care organizations supplement Medicaid services by offering value-added benefits to improve quality of life for members, their family and the community. 

"Sunflower Health Plan has been providing healthcare services and programs in the State of Kansas since 2013," said Christopher Bowers, Executive Vice President, Markets, for Centene. "We look forward to continuing our partnership with the state and all stakeholders to provide better health outcomes for Kansas residents at a lower cost to the state."

"Sunflower Health Plan is committed to ensuring Kansas' vulnerable populations have access to the quality, comprehensive healthcare they deserve," said Chris Coffey, President and CEO for Sunflower Health Plan. "We appreciate Governor Colyer's passion for KanCare, and thank him for his collaboration throughout the past years."

Over the past five years, Sunflower has partnered with local providers and community groups to support members in their personal health and wellness goals. This impact on its membership has resulted in satisfaction scores and health outcomes earning the health plan a Commendable NCQA accreditation status.

Sunflower Health Plan currently serves approximately 130,000 members in the KanCare program.

About Centene Corporation 
Centene Corporation, a Fortune 100 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long-Term Services and Supports (LTSS), in addition to other state-sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as "Part D"), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans Affairs. Centene also provides healthcare services to groups and individuals delivered through commercial health plans. Centene operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, commercial programs, home-based primary care services, life and health management, vision benefits management, pharmacy benefits management, specialty pharmacy and telehealth services.

Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://www.centene.com/investors.

Forward-Looking Statements
The company and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act ("PSLRA") of 1995, including statements in this and other press releases, in presentations, filings with the Securities and Exchange Commission ("SEC"), reports to stockholders and in meetings with investors and analysts. In particular, the information provided in this press release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Centene and certain plans and objectives of Centene with respect thereto, including but not limited to the expected benefits of the acquisition ("Health Net Acquisition") of Health Net, Inc. ("Health Net") and the proposed acquisition of New York State Catholic Health Plan, Inc., d/b/a Fidelis Care New York ("Fidelis Care") ("Proposed Fidelis Acquisition" or "Fidelis Care Transaction"). These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Without limiting the foregoing, forward-looking statements often use words such as "anticipate", "seek", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "hope", "aim", "continue", "will", "may", "can", "would", "could" or "should" or other words of similar meaning or the negative thereof. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in PSLRA. A number of factors, variables or events could cause actual plans and results to differ materially from those expressed or implied in forward-looking statements. Such factors include, but are not limited to, Centene's ability to accurately predict and effectively manage health benefits and other operating expenses and reserves; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder that may result from changing political conditions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting Centene's government businesses; Centene's ability to adequately price products on federally facilitated and state based Health Insurance Marketplaces; tax matters; disasters or major epidemics; the outcome of legal and regulatory proceedings; changes in expected contract start dates; provider, state, federal and other contract changes and timing of regulatory approval of contracts; the expiration, suspension or termination of Centene or Fidelis Care's contracts with federal or state governments (including but not limited to Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of pending or future litigation or government investigations; challenges to Centene or Fidelis Care's contract awards; cyber-attacks or other privacy or data security incidents; the possibility that the expected synergies and value creation from acquired businesses, including, without limitation, the Health Net Acquisition and the Proposed Fidelis Acquisition, will not be realized, or will not be realized within the expected time period, including, but not limited to, as a result of any failure to obtain any regulatory, governmental or third party consents or approvals in connection with the Proposed Fidelis Acquisition or any conditions, terms, obligations or restrictions imposed in connection with the receipt of such consents or approvals; the exertion of management's time and Centene's resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for the Health Net Acquisition or the Proposed Fidelis Acquisition; disruption caused by significant completed and pending acquisitions, including the Health Net Acquisition and the Proposed Fidelis Acquisition, making it more difficult to maintain business and operational relationships; the risk that unexpected costs will be incurred in connection with the completion and/or integration of acquisition transactions, including among others, the Health Net Acquisition and the Proposed Fidelis Acquisition; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses and pending acquisitions, including Health Net and Fidelis Care, will not be integrated successfully; the risk that the conditions to the completion of the Proposed Fidelis Acquisition may not be satisfied or completed on a timely basis, or at all; failure to obtain or receive any required regulatory approvals, consents or clearances for the Proposed Fidelis Acquisition, and the risk that, even if so obtained or received, regulatory authorities impose conditions on the completion of the transaction that could require the exertion of management's time and Centene's resources, or otherwise have an adverse effect on Centene or the completion of the Proposed Fidelis Acquisition; business uncertainties and contractual restrictions while the Proposed Fidelis Acquisition is pending, which could adversely affect Centene's business and operations; change of control provisions or other provisions in certain agreements to which Fidelis Care is a party, which may be triggered by the completion of the Proposed Fidelis Acquisition; loss of management personnel and other key employees due to uncertainties associated with the Proposed Fidelis Acquisition; the risk that, following completion of the Proposed Fidelis Acquisition, the combined company may not be able to effectively manage its expanded operations; restrictions and limitations that may stem from the financing arrangements that the combined company will enter into in connection with the Proposed Fidelis Acquisition; Centene's ability to achieve improvement in the Centers for Medicare and Medicaid Services ("CMS") Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to Centene; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the SEC. These forward-looking statements reflect Centene's current views with respect to future events and are based on numerous assumptions and assessments made by Centene in light of its experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this press release could cause Centene's plans with respect to the Health Net Acquisition, actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is currently believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and persons reading this press release are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as of the date of this press release. Centene does not assume any obligation to update the information contained in this press release (whether as a result of new information, future events or otherwise), except as required by applicable law. This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other risk factors that may affect Centene's business operations, financial condition and results of operations, in Centene's filings with the SEC, including the annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

 

Cision View original content:http://www.prnewswire.com/news-releases/centenes-kansas-subsidiary-wins-medicaid-contract-300670853.html

SOURCE Centene Corporation


© PRNewswire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CENTENE CORPORATION
06/22CENTENE : Kansas Subsidiary Wins Medicaid Contract
PR
06/22CENTENE : Sen. Donnelly Issues Statement on 2019 Plans on Indiana Health Insuran..
AQ
06/22CENTENE : And National Council On Independent Living Partner To Increase Provide..
AQ
06/21CENTENE : Subsidiary Re-Awarded Correctional Healthcare Contract In New Hampshir..
AQ
06/21CENTENE : and CareSource file their proposed 2019 plans for Indiana's individual..
AQ
06/15CENTENE : New York AG approves Centene's nearly $4 billion purchase of Fidelis
AQ
06/14CENTENE : Initiative Aims to Increase Provider Accessibility for People with Dis..
AQ
06/14CENTENE CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/14CENTENE : Receives New York Attorney General Approval of Fidelis Care Transactio..
PR
06/13CENTENE : And National Council On Independent Living Partner To Increase Provide..
PR
More news
News from SeekingAlpha
06/18Centene (CNC) Investor Presentation - Slideshow 
06/18Game Plan For The Week - Cramer's Mad Money (6/15/18) 
06/14New York AG on board with Centene takeover of Fidelis Care 
06/12Centene re-awarded services contract from New Hampshire DOC 
06/11Game Plan For The Week - Cramer's Mad Money (6/8/18) 
Financials ($)
Sales 2018 58 788 M
EBIT 2018 2 186 M
Net income 2018 955 M
Finance 2018 1 624 M
Yield 2018 -
P/E ratio 2018 25,20
P/E ratio 2019 17,62
EV / Sales 2018 0,36x
EV / Sales 2019 0,33x
Capitalization 22 733 M
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | CNC | US15135B1017 | 4-Traders
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 136 $
Spread / Average Target 8,6%
EPS Revisions
Managers
NameTitle
Michael F. Neidorff Chairman & Chief Executive Officer
Claudio Abreu EVP, Specialized Markets & Business Operations
Jeffrey A. Schwaneke Chief Financial Officer, Treasurer & Executive VP
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CENTENE CORPORATION24.50%22 733
UNITEDHEALTH GROUP15.38%244 445
ANTHEM INC8.80%62 478
AETNA5.84%62 450
CIGNA-14.28%42 348
HUMANA20.93%41 302